Repligen | RGEN - Kısa Vadeli Yükümlülükler





Kısa Vadeli Yükümlülükler Değişiklik Tarih
Agilent USD 2.27B 35M 2026-03
Align Technology USD 1.91B 2.74M 2026-06
Bio Techne USD 153.28M 12.85M 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Bruker USD 1.36B 75.9M 2026-03
Charles River Laboratories USD 1.09B 26.61M 2026-03
Danaher USD 8.1B 645M 2026-06
Dentsply International USD 1.21B 136M 2026-03
General Electric Aerospace USD 40.43B 403M 2026-06
Henry Schein USD 3.3B 69M 2026-03
Illumina USD 1.58B 12M 2026-06
IQVIA Holdings USD 8.82B 486M 2026-06
Mettler Toledo International USD 1.2B 92.14M 2026-06
Myriad Genetics USD 130.7M 500K 2026-06
OraSure Technologies USD 44.08M 4.29M 2026-03
Pacific Biosciences Of California USD 65.36M 7.48M 2026-03
Pfizer USD 34.35B 2.64B 2026-03
Repligen USD 132.66M 6.45M 2026-06
Revvity USD 1.24B 92.6M 2026-03
Standard Biotools USD 42.2M 66.1M 2026-03
Thermo Fisher Scientific USD 15.07B 448M 2026-06
Waters USD 1.24B 11.8M 2025-12
West Pharmaceutical Services USD 640.5M 33.5M 2026-06